Nucula’s new indication is as an add-on therapy for patients with COPD who also have an elevated blood eosinophil count.

The Consumer Brands Association argues the CPG industry has been ‘putting the transparency into ‘radical transparency’ for ...

Hearings were originally scheduled for this week on SB 2385 and HB 3350, which would stop drugmakers from cutting off steep ...

Corporate influence The report claims that industry-funded research outpaces public funding, with the chemical industry ...

Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this ...

FDA announced efforts to streamline its drug importation process to help U.S. states and Native American tribes access ...

Amid concerns about FDA’s capacity to meet safety mandates following the departure of 3,500 employee since January, the ...

Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and ...

The Food and Drug Administration (FDA) announced Wednesday plans to help states and Indian tribes import cheaper prescription ...

The FDA ODAC decided that the overall benefit-risk of the investigational therapy UGN-102 is not favorable in patients with ...

Due to technical difficulties, this program will be available to stream at a later time. Federal health policy has seen major shifts, leaving millions of families and older Americans with new ...

The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...